Biotest Aktiengesellschaft
FSX:BIO3.DE
Overview | Financials
Company Name | Biotest Aktiengesellschaft |
Symbol | BIO3.DE |
Currency | EUR |
Price | 27.1 |
Market Cap | 1,342,454,218 |
Dividend Yield | 0.14% |
52-week-range | 22.8 - 31.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Michael Ramroth |
Website | https://www.biotest.com |
An error occurred while fetching data.
About Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD